PanTera-preview

Pantera-life

PanTera

Private

MolHealthcare & Life Scienceshttps://pantera-life.com/

Last Round

Series A

Sep 11, 2024

Est. Valuation

$308.3M

Total Funding Raised

$110.3M

Momentum Score

25 /100

Company Overview

PanTera is a life sciences company that produces actinium-225, a radioisotope used in next-generation radiopharmaceuticals for targeted cancer therapy.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

actinium-225 productionAc-225 supplytargeted alpha therapyTATradiopharmaradioisotope manufacturingmedical isotope supplyalpha-emitting radioisotopeactive pharmaceutical ingredientAPIradiopharmaceutical therapyphotonuclear productionpharma supply chainclinical trial supply

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PanTera Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PanTera Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Sep 11, 2024
Debt	Sep 11, 2024
Convertible Debt	Sep 22, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Samy Bertrand

CTO

Executive Team

PanTera Investors

Notable investors and investment history

Investor	Rounds
Federal Holding and Investment Company	Convertible Debt, Series A
EQT Life Sciences	Series A
Korys	Series A
Paladin Capital Group	Series A
KBC Group N.V.	Debt
PMV	Series A
Eurazeo	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 22, 2025
Grew 19% QoQ, from 42 to 50 employees.
Nov 7, 2025
Monthly visitors increased 50% MoM.

View all signals

PanTera Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PanTera Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PanTera's valuation, stock price, and market status.

Firmographic Details

HeadquartersMol

Employee Range52

Year Founded2022

Last FundingSep 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.